Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Kite Pharma Inc (NASDAQ: KITE) hopes to seek regulatory approval next year for a treatment for a form of lymphoma, an analyst said Wednesday.
Jefferies' Biren Amin reiterated a Buy rating and $83 target following Kite executives meeting with analysts in New York Tuesday.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Canaccord's John Newman also reaffirmed a Buy rating on Kite with a $90 target.
Kite may file a biologic license application next year for its KTE-C19 drug as a treatment for diffuse large B-cell lymphoma, according to Amin.
The company expects to release interim results of a related lymphoma study in December at the annual meeting of the American Society of Hematology.
That study is aimed at gauging toxicity of the drug, according to Newman, who also expects Kite to start human testing later this year on drugs related to a form of human papillomavirus as well as colorectal, lung, and pancreatic cancers.
"Those are three very large commercial markets," Newman said.
Kite also hopes to file an investigational new drug application in the first half of 2016 related to two further anti-cancer antigens, Amin said.
The IND application would enable clinical trials to commence.
Separately, Kite on Tuesday unveiled a partnership with bluebird bio Inc (NASDAQ: BLUE) to develop and market T-cell therapies for HPV-associated cancers.
Kite, which has gained nearly 11 percent in the past five trading days, changed hands recently at $63.19, up $0.47.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.